Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,720	5,347	5,390	6,295	9,629	5,710
Trading Asset Securities	1,103	0.47	0.47	0.47	0.47	1,330
Cash & Short-Term Investments	9,823	5,347	5,391	6,295	9,629	7,040
Cash Growth	111.91%	-0.81%	-14.37%	-34.62%	36.78%	474.40%
Accounts Receivable	560.6	459.88	385.52	463.56	275.22	294.95
Other Receivables	4.66	10.56	10.35	11.79	6.58	8.32
Receivables	565.26	470.43	395.88	475.35	281.8	303.27
Inventory	1,162	1,181	1,466	1,574	1,185	775.1
Prepaid Expenses	2.76	7.29	10.57	-	-	0.14
Other Current Assets	458.6	381.4	307.18	131.44	298.68	325.91
Total Current Assets	12,012	7,387	7,571	8,475	11,395	8,444
Property, Plant & Equipment	9,906	9,849	9,376	6,670	2,969	2,789
Long-Term Investments	153.25	133.78	142.73	49.51	53.21	56.18
Other Intangible Assets	690.14	685.04	703.85	777.87	768.46	228.44
Long-Term Deferred Tax Assets	239.33	210.37	158.88	88.28	52.2	36.65
Long-Term Deferred Charges	4.59	6.42	4.98	7.17	9.58	7.87
Other Long-Term Assets	815.83	750.4	876.48	1,759	938.51	572.25
Total Assets	23,821	19,021	18,833	17,827	16,185	12,135
Accounts Payable	194.12	135.44	167.85	240.08	248.83	205.25
Accrued Expenses	42.6	30.32	21.54	32.47	42.34	35.66
Short-Term Debt	50.38	1,247	746.25	161.47	743.51	-
Current Portion of Long-Term Debt	11.91	37.17	784.37	5.38	-	-
Current Income Taxes Payable	27.13	32.94	55.54	30.7	45.4	19.28
Current Unearned Revenue	36.24	35.81	10.48	17.81	14.64	19.9
Other Current Liabilities	1,514	1,399	1,624	936.28	123.01	154.68
Total Current Liabilities	1,876	2,918	3,410	1,424	1,218	434.77
Long-Term Debt	492.68	613.26	245.33	960.5	-	-
Long-Term Unearned Revenue	377.24	389.29	405.18	404.39	293.03	214.6
Long-Term Deferred Tax Liabilities	0.33	-	-	-	-	1.37
Total Liabilities	2,746	3,920	4,060	2,789	1,511	650.74
Common Stock	721.29	583.38	583.38	583.28	416.68	416.68
Additional Paid-In Capital	14,300	8,520	8,526	8,540	8,688	8,681
Retained Earnings	2,567	2,546	2,167	1,905	1,539	1,278
Treasury Stock	-155.63	-155.13	-126.19	-94.67	-	-
Comprehensive Income & Other	20.06	12.77	14.45	14.69	8.23	8.68
Total Common Equity	17,453	11,507	11,164	10,949	10,652	10,385
Minority Interest	3,622	3,594	3,609	4,089	4,022	1,100
Shareholders' Equity	21,075	15,101	14,773	15,038	14,674	11,484
Total Liabilities & Equity	23,821	19,021	18,833	17,827	16,185	12,135
Total Debt	554.98	1,897	1,776	1,127	743.51	-
Net Cash (Debt)	9,268	3,450	3,615	5,168	8,886	7,040
Net Cash Growth	178.80%	-4.56%	-30.05%	-41.84%	26.22%	660.78%
Net Cash Per Share	15.05	5.93	6.21	8.87	15.24	12.97
Filing Date Shares Outstanding	718.04	718.95	581.32	582.15	583.35	583.35
Total Common Shares Outstanding	718.04	582.75	581.68	582.15	583.35	583.35
Working Capital	10,136	4,469	4,161	7,051	10,177	8,010
Book Value Per Share	24.31	19.75	19.19	18.81	18.26	17.80
Tangible Book Value	16,762	10,822	10,460	10,171	9,883	10,156
Tangible Book Value Per Share	23.34	18.57	17.98	17.47	16.94	17.41
Buildings	1,959	1,958	1,815	1,357	988.18	599.56
Machinery	3,334	3,330	3,216	2,979	1,807	1,002
Construction In Progress	6,147	5,949	5,443	3,164	758.31	1,610

Source: S&P Global Market Intelligence. Standard template. Financial Sources.